- Thyroid Scintigraphy, Free T3, Free T4, TSH, Open Access Library" />

全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Correlation between 99mTcO4- Thyroid Scintigraphy and Blood Test in Primary Hyperthyroidism

DOI: 10.4236/ojemd.2021.113006, PP. 71-78

Keywords: Graves’ Disease/Basedow’s Disease, 99mTcO4">- Thyroid Scintigraphy, Free T3, Free T4, TSH

Full-Text   Cite this paper   Add to My Lib

Abstract:

Background: The 99mTcO4- thyroid scintigraphy is commonly used for hyperthyroidism diagnosis. Uptake value of 99mTcO4- on thyroid scintigraphy is an indicator of hyperthyroidism activity. Although, the correlation between free T3 value and free T4 value is not necessary clear in primary hyperthyroidism. Introduction: This study investigated the correlation between results of blood test and uptake of 99mTcO4- on thyroid scintigraphy in primary hyperthyroidism. Methodlogy: In this retrspective study, uptake was calculated in patients diagnosed with primary hyperthyroidism (Graves’ disease/Basedow’s disease) based on clinical findings, blood tests, thyroid ultrasound, and 99mTcO4- thyroid scintigraphy (uptake ≥3%) at St. Marianna University School of Medicine Hospital between 1 January 2010 and 31 December 2019. This uptake of 99mTcO4- was compared with results of blood tests. Results: Fifty-four consecutively arriving patients at the hospital (12 men, 42 women; mean age 43.0 ± 14.0 years) were selected. Free T3 (n = 54) was 14.6 ± 6.8 pg/mL, free T4 (n = 53) was 5.0 ± 2.3 ng/mL, and uptake on thyroid scintigraphy was 10.0% ± 7.1%. The correlation coefficients were 0.60 (p < 0.01) between free T4 (all case), 0.39 (p < 0.01) between free T4 (under 7 ng/mL), 0.12 (p = 0.70) between free T4 (above 7 ng/mL) and 99mTcO4-?thyroid scintigraphy uptake. Conclusion: In primary hyperthyroidism (Graves’ disease), there is a correlation between free T4 value and 99mTcO4- thyroid scintigraphy uptake, but there is no correlation in patients with high free T4 level.

References

[1]  Japan Thyroid Association (2010) Guidelines for the Diagnosis of Thyroid Disease.
http://www.japanthyroid.jp/doctor/guideline/japanese.html
[2]  Kubo, A. and Kinoshita, O.F. (2020) Nuclear Medicine Notebook. 6th Edition, Kanehara & Co. Ltd., Tokyo, 133-146.
[3]  Singhal, N., Praveen, V.P., Bhavani, N., Menon, A.S., Menon, U., et al. (2016) Technetium Uptake Predicts Remission and Relapse in Grave’s Disease Patients on Antithyroid Drugs for at Least 1 Year in South Indian Subjects. Indian Journal of Endocrinology and Metabolism, 20, 157-161.
https://doi.org/10.4103/2230-8210.176360
[4]  Hou, H.F., Hu, S., Fan, R., Sun, W., Zhang, X.F., et al. (2015) Prognostic Value of 99mTc-Pertechnetate Thyroid Scintigraphy in Radioiodine Therapy in a Cohort of Chinese Graves’ Disease Patients: A Pilot Clinical Study. BioMed Research International, 97, 4689.
https://doi.org/10.1155/2015/974689
[5]  Zantut-Wittmann, D.E., Ramos, C.D., Santos, A.O., Lima, M.M., Panzan, A.D., et al. (2005) High Pre-Therapy [99mTc]Pertechnetate Thyroid Uptake, Thyroid Size and Thyrostatic Drugs: Predictive Factors of Failure in [131I]Iodide Therapy in Graves’ Disease. Nuclear Medicine Communications, 26, 957-963.
https://doi.org/10.1097/01.mnm.0000183795.59097.42
[6]  Kidokoro-Kunii, Y., Emoto, N., Cho, K. and Oikawa, S. (2006) Analysis of the Factors Associated with Tc-99m Pertechnetate Uptake in Thyrotoxicosis and Graves’ Disease. Journal of Nippon Medical School, 73, 10-17.
https://doi.org/10.1272/jnms.73.10
[7]  Nakamura, H., Noh, J.Y., Itoh, K., Fukata, S., Miyauchi, Y., et al. (2007) Comparison of Methimazole and Propylthiouracil in Patients with Hyperthyroidism Caused by Graves’ Disease. The Journal of Clinical Endocrinology & Metabolism, 92, 2157-2162.
https://doi.org/10.1210/jc.2006-2135
[8]  Ohiduzzaman, M., Khatun, R., Reza, S., Kadir, M.A. and Akter, S. (2019) Thyroid Uptake of Tc-99m and Its Agreement with I-131 for Evaluation of Hyperthyroid Function. Universal Journal of Public Health, 7, 201-206.
https://doi.org/10.13189/ujph.2019.070502
[9]  Szumowski, P., Mojsak, M., Abdelrazek, S., Sykała, M., Amelian-Fiłonowicz, A., et al. (2016) Calculation of Therapeutic Activity of Radioiodine in Graves’ Disease by Means of Marinelli’s Formula, Using Technetium (99mTc) Scintigraphy. Endocrine, 54, 751-756.
https://doi.org/10.1007/s12020-016-1074-7
[10]  Lee, H., Kim, J.H., Kang, Y.K., Moon, J.H., So, Y., et al. (2016) Quantitative Single-Photon Emission Computed Tomography/Computed Tomography for Technetium Pertechnetate Thyroid Uptake Measurement. Medicine, 95, e4170.
https://doi.org/10.1097/MD.0000000000004170

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133